Two studies reviewing the clinical-pathological and molecular features of esophageal lipoma and liposarcoma found MDM2 amplification by fluorescence in situ hybridization in all cases, with some of these patients presenting recurrent disease [14, 76]. Here, MDM2 is linked to liposarcoma.